Tag: Oncology Diagnostics
Natera wins FDA breakthrough tag for a 12-cancer blood test
Natera's cell-free DNA screening assay earned FDA Breakthrough Device designation after the agency reviewed data across 12 cancer types.
Natera's cell-free DNA screening assay earned FDA Breakthrough Device designation after the agency reviewed data across 12 cancer types.